Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2006 by Helsinki University.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Helsinki University

ClinicalTrials.gov Identifier:

NCT00298337

First received: March 1, 2006

Last updated: October 17, 2006

Last verified: March 2006

History of Changes

Tracking Information

First Received Date ^ICMJE

March 1, 2006

Last Updated Date

October 17, 2006

Start Date ^ICMJE

October 1999

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00298337 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

Official Title ^ICMJE

Not Provided

Brief Summary

The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Phase 2
Phase 3

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention

Condition ^ICMJE

Atopic Dermatitis
Food Hypersensitivity
Allergic Rhinitis, Seasonal
Allergic Conjunctivitis
Asthma

Intervention ^ICMJE

Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide

Study Arm (s)

Not Provided

Publications *

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Active, not recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

December 2007

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

mother or father fo child with doctor diagnoses allergic disease

Exclusion Criteria:

prematurity, major malformations

Gender

Both

Ages

37 Weeks to 42 Weeks

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Finland

Administrative Information

NCT Number ^ICMJE

NCT00298337

Other Study ID Numbers ^ICMJE

T101060058;T1040A0002;T110612

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Helsinki University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Chair:

Erkki Savilahti, Professor

Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland

Information Provided By

Helsinki University

Verification Date

March 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top